RETRACTED: Beneficial effect of etidronate therapy in chronically hospitalized, disabled patients with stroke.
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal).
This article has been retracted at the request of the Editor-in-Chief due to data fabrication, systematic authorship misconduct, text duplication, concerns about data integrity, and scientific misconduct. In addition, several publications reporting non-randomized research by members of this group of investigators have been retracted.
Sato
Yoshihiro
Y
Department of Neurology, Mitate Hospital, Tagawa, Japan. Electronic address: y-sato@ktarn.or.jp.
Iwamoto
Jun
J
Department of Sports Medicine, Keio University School of Medicine, Tokyo, Japan.
Honda
Yoshiaki
Y
Department of Neurology, Mitate Hospital, Tagawa, Japan.
D000368:Aged; D015992:Body Mass Index; D015519:Bone Density / Q000187:drug effects; D050071:Bone Density Conservation Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002118:Calcium / Q000378:metabolism; D002908:Chronic Disease; D006233:Persons with Disabilities; D018450:Disease Progression; D004311:Double-Blind Method; D012968:Etidronic Acid / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006620:Hip Fractures / Q000453:epidemiology / Q000517:prevention & control; D006760:Hospitalization; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000150:complications / Q000517:prevention & control*; D010281:Parathyroid Hormone / Q000097:blood; D020521:Stroke / Q000150:complications*; D013472:Sunlight; D014807:Vitamin D / Q000378:metabolism
D050071:Bone Density Conservation Agents; D010281:Parathyroid Hormone; D014807:Vitamin D; D012968:Etidronic Acid; D002118:Calcium